US9238657 — Cephalosporin having catechol group
Method of Use · Assigned to Shionogi and Co Ltd · Expires 2033-11-14 · 7y remaining
What this patent protects
This patent describes a class of Cephem compounds with a catechol group, specifically those of the formula: wherein X, T, A, G, B, D, F, R3, R4, R5, and R6 are defined.
USPTO Abstract
The present disclosure describes Cephem compounds of the formula: wherein, X is N, CH or CâCl; T is S or the like; A and G are lower alkylene or the like; B is a single bond or the like; D is optionally present, and when present is, âNR7â, âCOâ, âCOâNR7â, âNR7âCOâ, âNR7âCOâNR7â, or the like; F is optionally present, and when present is or phenylene; R3 and R4 are âOR8; R5 and R6 each is independently hydrogen, halogen, nitrile, or âOR8; or an ester at the carboxyl at the 7-position side chain or at the 4-position, a compound protected at the amino on the ring in the 7-side chain, a pharmaceutically acceptable salt, or a solvate thereof, which have a wide antimicrobial spectrum and have potent antimicrobial activity against beta-lactamase producing Gram negative bacteria.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-282 |
— | cefiderocol-sulfate-tosylate |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.